BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to HCC1937 cell line is 887
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALDH1A3 | 409 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | IF staining followed by ALDEFLUOR assay | NA | 0.36 | 0.0201 | 30647492 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | SFA followed by qRT-PCR and FACs | NA | 0.32 | 1 | 34023418 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs followed by qRT-PCR | NA | 0.32 | 1 | 31273285 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | Western Blotting | NA | 0.32 | 1 | 30139970 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | SFA and FACs | NA | 0.32 | 1 | 33390847 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs | NA | 0.32 | 1 | 29197410 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs | NA | 0.32 | 1 | 29249690 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs | NA | 0.32 | 1 | 31709178 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs | NA | 0.32 | 1 | 31729259 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs followed by SFA | NA | 0.32 | 1 | 29679903 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs followed by SFA | NA | 0.32 | 1 | 30227220 |
| CD44 | 1681 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | NA | 0.32 | 1 | 31709178 |
| GABRP | 4089 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0032 | 34023418 |
| HES1 | 5192 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | SFA and Western Blotting | NA | 0.28 | 0.0095 | 33390847 |
| NANOG | 20857 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | SFA and Western Blotting | NA | 0.28 | 0.5461 | 33390847 |
| NANOG | 20857 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | Western Blotting followed by SFA | NA | 0.28 | 0.5461 | 29679903 |
| NANOG | 20857 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | IF staining followed by SFA | NA | 0.28 | 0.5461 | 34889737 |
| POU5F1 | 9221 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | SFA and Western Blotting | NA | 0.28 | 0.6448 | 33390847 |
| POU5F1 | 9221 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | IF staining followed by SFA | NA | 0.28 | 0.6448 | 34889737 |
| SNAI2 | 11094 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | SFA and Western Blotting | NA | 0.28 | 0.0159 | 33390847 |
| SOX2 | 11195 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | SFA and Western Blotting | NA | 0.28 | 0.5695 | 33390847 |
| SOX2 | 11195 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | IF staining followed by SFA | NA | 0.28 | 0.5695 | 34889737 |
| SOX2 | 11195 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | qRT-PCR | NA | 0.28 | 0.5695 | 31273285 |
| FA2H | 21197 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.24 | 0.0042 | 31709178 |
| FA2H | 21197 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.24 | 0.0042 | 31709178 |
| IL6 | 6018 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.24 | 0.0191 | 31709178 |
| TGFBR2 | 11773 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.24 | 0.0032 | 31709178 |
| TGFBR2 | 11773 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.24 | 0.0032 | 31709178 |
| FA2H | 21197 | HTM/LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics and qPCR | Up | 0.24 | 0.0042 | 31729259 |
| IL6 | 6018 | HTM/LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics and qPCR | Up | 0.24 | 0.0191 | 31729259 |
| TGFBR2 | 11773 | HTM/LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics and qPCR | Up | 0.24 | 0.0032 | 31729259 |
| MYC | 7553 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | IF staining followed by SFA | NA | 0.24 | 0.1304 | 34889737 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.684 | 34023418 |
| ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | ALDEFLUOR assay | NA | 0.2 | 0.684 | 31273285 |
| ASCL1 | 738 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | qRT-PCR | NA | 0.2 | 0.0011 | 31273285 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | qRT-PCR | NA | 0.2 | 0.456 | 31273285 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs | NA | 0.2 | 0.456 | 29197410 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs | NA | 0.2 | 0.456 | 29249690 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs | NA | 0.2 | 0.456 | 31709178 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs | NA | 0.2 | 0.456 | 31729259 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs followed by SFA | NA | 0.2 | 0.456 | 29679903 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs followed by SFA | NA | 0.2 | 0.456 | 30227220 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | NA | 0.2 | 0.456 | 31709178 |
| MSI1 | 7330 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | qRT-PCR | NA | 0.2 | 0.0201 | 31273285 |
| CD24 | 1645 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.12 | 0.456 | 31709178 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | SFA and FACs | NA | 0.12 | 0.456 | 33390847 |
| CD24 | 1645 | LTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | SFA followed by FACs | NA | 0.12 | 0.456 | 34023418 |
| ABAT | 23 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ABCA1 | 29 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| ABCA12 | 14637 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| ABCA4 | 34 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ABCC2 | 53 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0106 | 31709178 |
| ABCC9 | 60 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| ABHD11 | 16407 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ABI3BP | 17265 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| ABLIM2 | 19195 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ABRACL | 21230 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ACE2 | 13557 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ADAM12 | 190 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| ADAM19 | 197 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| ADAMTS10 | 13201 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| ADAMTS14 | 14899 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ADAMTS2 | 218 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| ADAMTS4 | 220 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| ADAMTSL1 | 14632 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| ADAP1 | 16486 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ADD2 | 244 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| ADGRB2 | 944 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| ADGRE2 | 3337 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| ADGRF1 | 18990 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| ADGRL2 | 18582 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| AGR2 | 328 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31709178 |
| AGR2 | 328 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31729259 |
| AHRR | 346 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| AIF1L | 28904 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| AIFM3 | 26398 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| AKR1C1 | 384 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0085 | 31709178 |
| ALDH3B2 | 411 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ALDH5A1 | 408 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ALOX12B | 430 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ALOX12P2 | 432 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ALOX15B | 434 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ALOX15B | 434 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ALPP | 439 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ALS2CL | 20605 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| AMZ1 | 22231 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ANKRD22 | 28321 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ANO1 | 21625 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| ANO9 | 20679 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ANTXR1 | 21014 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| ANTXR2 | 21732 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| ANXA3 | 541 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0085 | 31709178 |
| ANXA8 | 546 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| ANXA8L1 | 23334 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| ANXA9 | 547 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| AOX1 | 553 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| AP1M2 | 558 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| AP1S3 | 18971 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| APCDD1L | 26892 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| APCDD1L-DT | 27152 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| APOBEC3B | 17352 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| AQP3 | 636 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| ARAP2 | 16924 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| AREG | 651 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31709178 |
| ARHGAP27 | 31813 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ARHGAP30 | 27414 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ARHGAP31 | 29216 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| ARHGAP40 | 16226 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ARHGDIB | 679 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| ARHGEF16 | 15515 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ARHGEF34P | 38086 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ARHGEF35 | 33846 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ARHGEF37 | 34430 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ARHGEF5 | 13209 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ARL10 | 22042 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| ARL14 | 22974 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ARSB | 714 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| ARVCF | 728 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ATP2C2 | 29103 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ATP6V1B1 | 853 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| ATP6V1C2 | 18264 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ATP8B2 | 13534 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| AXL | 905 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| B3GNT3 | 13528 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| B4GAT1 | 15685 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| BARX2 | 956 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| BCAT1 | 976 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| BCL2L14 | 16657 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| BCORL1 | 25657 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| BDKRB1 | 1029 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| BDNF | 1033 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 31709178 |
| BHLHE41 | 16617 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| BICDL1 | 28095 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| BICDL2 | 33584 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| BIK | 1051 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| BLACAT1 | 48597 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| BLMH | 1059 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 31709178 |
| BMP4 | 1071 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| BNC2 | 30988 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| BSPRY | 18232 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| BTBD11 | 23844 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| BTG2 | 1131 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| C15ORF48 | 29898 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| C1ORF116 | 28667 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| C1R | 1246 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| C6ORF132 | 21288 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CA12 | 1371 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| CALB1 | 1434 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CALB2 | 1435 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| CALML5 | 18180 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CAMKK1 | 1469 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| CAMSAP3 | 29307 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CAPN1 | 1476 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CAPN8 | 1485 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CARD11 | 16393 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CASP10 | 1500 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CASP14 | 1502 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CASTOR3 | 29954 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CBLC | 15961 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CCDC120 | 28910 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CCDC33 | 26552 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CCDC88A | 25523 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| CCL28 | 17700 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CD14 | 1628 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| CD74 | 1697 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| CD9 | 1709 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| CD99L2 | 18237 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| CDC42BPG | 29829 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CDH1 | 1748 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| CDH11 | 1750 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| CDH13 | 1753 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| CDH2 | 1759 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0085 | 31709178 |
| CDH3 | 1762 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CDS1 | 1800 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CEACAM1 | 1814 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31709178 |
| CELSR2 | 3231 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| CEMIP | 29213 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| CFL2 | 1875 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| CFL2 | 1875 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31729259 |
| CGN | 17429 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| CHD5 | 16816 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CHI3L1 | 1932 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| CHMP4C | 30599 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CHRDL1 | 29861 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| CHRNB1 | 1961 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CLDN11 | 8514 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| CLDN23 | 17591 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CLDN3 | 2045 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CLDN4 | 2046 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| CLDN7 | 2049 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CLDN9 | 2051 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CLEC2D | 14351 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CMTM7 | 19178 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CMYA5 | 14305 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CNKSR1 | 19700 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CNTNAP1 | 8011 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| COBLL1 | 23571 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| COL17A1 | 2194 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31709178 |
| COL4A1 | 2202 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| COL4A2 | 2203 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| COL5A1 | 2209 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| COL8A1 | 2215 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| COMTD1 | 26309 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| COX6B2 | 24380 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CPA4 | 15740 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| CPED1 | 26159 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| CPM | 2311 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 31709178 |
| CRABP2 | 2339 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CRACR2B | 28703 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CRB3 | 20237 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CREB3L1 | 18856 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| CRYBG2 | 17295 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CSF1 | 2432 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| CSF3 | 2438 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| CSGALNACT1 | 24290 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| CSMD2 | 19290 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| CST6 | 2478 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CSTB | 2482 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| CTH | 2501 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CTSH | 2535 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CXCL1 | 4602 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0064 | 31709178 |
| CXCL16 | 16642 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| CXCL2 | 4603 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0074 | 31709178 |
| CXCL3 | 4604 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| CXCL5 | 10642 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| CXCL6 | 10643 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| CYP1B1 | 2597 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0064 | 31709178 |
| CYP26B1 | 20581 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| CYP4F11 | 13265 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| CYP4F12 | 18857 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| CYR61 | 2654 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 31709178 |
| DAAM1 | 18142 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| DAB2 | 2662 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| DAB2IP | 17294 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| DAPP1 | 16500 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| DDIT4L | 30555 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| DDR2 | 2731 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| DEF6 | 2760 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| DENND1C | 26225 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| DENND2D | 26192 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| DENND5B | 28338 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| DHDH | 17887 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| DIO2 | 2884 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| DIO3 | 2885 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| DKK3 | 2893 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| DLC1 | 2897 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| DLG3 | 2902 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| DMTN | 3382 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| DNAH2 | 2948 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| DNER | 24456 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| DOCK4 | 19192 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| DPYSL2 | 3014 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| DSC2 | 3036 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| DSG3 | 3050 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| DSP | 3052 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| DTX4 | 29151 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| DUOX1 | 3062 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| DUOX2 | 13273 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| DYNC2H1 | 2962 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| DYRK3 | 3094 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| EBI3 | 3129 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| EDN1 | 3176 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| EFEMP1 | 3218 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0064 | 31709178 |
| EFNA1 | 3221 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| EHD3 | 3244 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| ELF3 | 3318 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| ELMO3 | 17289 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| EML1 | 3330 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| EMP1 | 3333 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| EMP2 | 3334 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| EMP3 | 3335 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| ENDOD1 | 29129 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| ENPP2 | 3357 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| ENPP5 | 13717 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ENTPD2 | 3364 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ENTPD8 | 24860 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| EPB41L1 | 3378 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| EPB41L4B | 19818 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| EPCAM | 11529 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.211 | 31709178 |
| EPGN | 17470 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| EPHA1 | 3385 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| EPHB3 | 3394 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| EPPK1 | 15577 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| EPS8L1 | 21295 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| EPS8L2 | 21296 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ERBB3 | 3431 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| EREG | 3443 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| ERMP1 | 23703 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ESM1 | 3466 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| ESPN | 13281 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ESR1 | 3467 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| ESRP1 | 25966 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ESRP2 | 26152 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ETV1 | 3490 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| EVC | 3497 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| EVPL | 3503 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| F12 | 3530 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| F2R | 3537 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| F2RL1 | 3538 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| FAAH | 3553 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| FAAH2 | 26440 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| FAM102B | 27637 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| FAM110A | 16188 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| FAM110C | 33340 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| FAM126A | 24587 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| FAM126A | 24587 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31729259 |
| FAM160A1 | 34237 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| FAM167A | 15549 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| FAM174B | 34339 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| FAM83A-AS1 | 48658 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| FAM83B | 21357 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| FAP | 3590 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| FBLN1 | 3600 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| FBLN2 | 3601 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| FBN1 | 3603 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| FBP1 | 3606 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| FBP1 | 3606 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31729259 |
| FBXO2 | 13581 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| FBXO6 | 13585 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| FER1L4 | 15801 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| FGD4 | 19125 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| FGF1 | 3665 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| FGF2 | 3676 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 31709178 |
| FGF2 | 3676 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 31729259 |
| FGF2 | 3676 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 31729259 |
| FGFR1 | 3688 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 31709178 |
| FGFR2 | 3689 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| FLNC | 3756 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| FMN2 | 14074 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| FMNL3 | 23698 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| FN1 | 3778 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 31709178 |
| FNDC4 | 20239 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| FNIP2 | 29280 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| FOXA1 | 5021 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| FOXA1 | 5021 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31729259 |
| FOXC2 | 3801 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| FOXF1 | 3809 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| FOXQ1 | 20951 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| FRMD4A | 25491 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| FRMD4B | 24886 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| FRMD5 | 28214 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| FRRS1 | 27622 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| FSTL1 | 3972 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| FUCA1 | 4006 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| FUCA1 | 4006 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31729259 |
| FUT1 | 4012 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| FUT3 | 4014 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| FXYD3 | 4027 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| FZD4 | 4042 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| FZD6 | 4044 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| FZD8 | 4046 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| G0S2 | 30229 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| GAB1 | 4066 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| GAB2 | 14458 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| GALNT3 | 4125 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| GATA3 | 4172 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| GATA3 | 4172 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31729259 |
| GATM | 4175 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| GCKR | 4196 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| GFI1 | 4237 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| GFRA1 | 4243 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| GJA5 | 4279 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| GJB3 | 4285 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| GJB4 | 4286 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| GJB5 | 4287 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| GLCCI1 | 18713 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| GOLGA2P5 | 25315 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| GPR161 | 23694 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| GPR87 | 4538 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| GPRC5A | 9836 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| GPRIN2 | 23730 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| GRAMD2A | 27287 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| GRB10 | 4564 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| GRB7 | 4567 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| GRHL1 | 17923 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| GRHL2 | 2799 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| GSN | 4620 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| GSTA4 | 4629 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| HAP1 | 4812 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| HAS3 | 4820 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| HCAR1 | 4532 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| HCAR2 | 24827 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| HEG1 | 29227 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| HID1 | 15736 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| HIGD1A | 29527 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| HIPK2 | 14402 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| HOOK1 | 19884 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| HR | 5172 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| HSD17B11 | 22960 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| HSH2D | 24920 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| HTRA1 | 9476 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| IFI30 | 5398 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| IFNLR1 | 18584 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| IGFBP4 | 5473 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| IGFN1 | 24607 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| IGSF9 | 18132 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| IKBIP | 26430 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| IL13RA2 | 5975 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| IL1B | 5992 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0074 | 31709178 |
| IL1R2 | 5994 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| IL1RN | 6000 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| IL24 | 11346 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| IL2RG | 6010 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| IL2RG | 6010 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| IL36RN | 15561 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| IL7R | 6024 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| IL8 | 6025 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0159 | 31709178 |
| INAVA | 25599 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| INHA | 6065 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| INHBB | 6067 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31709178 |
| INSIG1 | 6083 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 31709178 |
| IRF5 | 6120 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| IRF6 | 6121 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| ITGA5 | 6141 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| ITGA7 | 6143 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| ITGB3 | 6156 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| ITGB4 | 6158 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0074 | 31709178 |
| ITGB6 | 6161 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| ITGB8 | 6163 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| ITPKC | 14897 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ITPR1 | 6180 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| JPH1 | 14201 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| JUp | 6207 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| KCNMA1 | 6284 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| KCNMA1 | 6284 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| KCNQ5 | 6299 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| KCNS1 | 6300 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| KDF1 | 26624 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| KIAA0040 | 28950 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| KIAA1522 | 29301 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| KIRREL1 | 15734 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| KLHDC7B | 25145 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| KLK10 | 6358 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| KLK5 | 6366 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| KLK6 | 6367 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| KLK7 | 6368 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| KLK8 | 6369 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| KLK9 | 6370 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| KLRG2 | 24778 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| KNDC1 | 29374 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| KREMEN2 | 18797 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| KRT15 | 6421 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| KRT16 | 6423 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31709178 |
| KRT17 | 6427 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31709178 |
| KRT18 | 6430 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0074 | 31709178 |
| KRT18 | 6430 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0074 | 31729259 |
| KRT18P11 | 6431 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| KRT18P17 | 33385 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| KRT18P29 | 33398 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| KRT5 | 6442 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31709178 |
| KRT6A | 6443 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| KRT6B | 6444 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| KRT8 | 6446 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0074 | 31709178 |
| KRT81 | 6458 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| KRT8P10 | 33364 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| KRT8P3 | 31056 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| KRT8P32 | 39866 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| KRT8P33 | 39867 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| KRT8P45 | 39879 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| LAD1 | 6472 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| LAMA3 | 6483 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| LAMC3 | 6494 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| LARGE2 | 16522 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| LCN2 | 6526 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| LCP1 | 6528 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| LEMD1 | 18725 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| LGALS9 | 6570 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| LHFP | 6586 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| LIFR | 6597 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| LIMS2 | 16084 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| LINC00514 | 27549 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| LIPH | 18483 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| LIX1L | 28715 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| LLGL2 | 6629 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| LMO4 | 6644 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| LMTK3 | 19295 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| LOX | 6664 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0074 | 31709178 |
| LOXL2 | 6666 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| LPAR5 | 13307 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| LRAT | 6685 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| LRG1 | 29480 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| LRIG1 | 17360 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 31709178 |
| LRRC1 | 14307 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| LRRC8B | 30692 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| LSR | 29572 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| LXN | 13347 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| LYN | 6735 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| MACsC1 | 30215 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| MAL | 6817 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MAL2 | 13634 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| MALL | 6818 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| MAMLD1 | 2568 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| MAP3K1 | 6848 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| MAP3K12 | 6851 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| MAP3K8 | 6860 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| MAP7 | 6869 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MARCO | 6895 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MARVELD3 | 30525 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MBOAT1 | 21579 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| MCAM | 6934 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0064 | 31709178 |
| MCF2L | 14576 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| MDFI | 6967 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MFNG | 7038 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| MFSD6 | 24711 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| MGST2 | 7063 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| MICALCL | 24693 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| MILR1 | 27570 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| MIR205HG | 43562 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MIR600HG | 23642 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MIR614 | 32870 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| MISP | 27000 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MMP16 | 7162 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| MMP2 | 7166 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| MPP7 | 26542 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| MPZL2 | 3496 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31709178 |
| MPZL3 | 27279 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| MRC2 | 16875 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| MREG | 25478 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| MSRB3 | 27375 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| MST1R | 7381 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| MTHFD2L | 31865 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| MTSS1 | 20443 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| MT-TE | 7479 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MT-TL1 | 7490 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MT-TS1 | 7497 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MT-TT | 7499 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MT-TY | 7502 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| MUC1 | 7508 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| MUC1 | 7508 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31729259 |
| MUC16 | 15582 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| MX1 | 7532 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| MYH14 | 23212 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| MYLK | 7590 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| MYLK | 7590 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31729259 |
| MYO1B | 7596 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| MYO1D | 7598 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| MYO5B | 7603 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| MYO5C | 7604 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| MYO6 | 7605 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| NAT1 | 7645 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| NCF2 | 7661 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| NCK2 | 7665 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| NCR3LG1 | 42400 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| NECTIN3 | 17664 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| NECTIN4 | 19688 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| NEDD9 | 7733 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| NEURL1 | 7761 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| NEURL3 | 25162 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| NFASC | 29866 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| NFATC2 | 7776 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| NFATC4 | 7778 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| NIBAN1 | 16784 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 31709178 |
| NID1 | 7821 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| NIPAL2 | 25854 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| NKX6-1 | 7839 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| NMB | 7842 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| NOXA1 | 10668 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| NPR3 | 7945 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| NRARP | 33843 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| NRP1 | 8004 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 31709178 |
| NRP2 | 8005 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| NT5E | 8021 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0095 | 31709178 |
| NTF4 | 8024 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| NXF3 | 8073 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| OAS1 | 8086 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| OAS2 | 8087 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| OCLN | 8104 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| OGFRL1 | 21378 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| OSBPL6 | 16388 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| OVOL1 | 8525 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| PACSIN1 | 8570 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PADI1 | 18367 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PADI2 | 18341 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PAK6 | 16061 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PALM | 8594 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| PARD6B | 16245 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PARM1 | 24536 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| PATJ | 28881 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| PBX1 | 8632 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| PCDH1 | 8655 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PCDHGA1 | 8696 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| PCSK5 | 8747 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PCSK9 | 20001 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| PDE4A | 8780 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| PERM1 | 28208 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PERP | 17637 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| PEX11G | 20208 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PI3 | 8947 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31709178 |
| PIGR | 8968 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PIK3IP1 | 24942 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PKD1L2 | 21715 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PKIG | 9019 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| PKP2 | 9024 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| PKP3 | 9025 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PLA2G4E | 24791 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PLAT | 9051 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0064 | 31709178 |
| PLEKHA7 | 27049 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PLEKHG3 | 20364 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PLEKHG6 | 25562 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PLEKHO2 | 30026 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| PLIN2 | 248 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0064 | 31709178 |
| PLIN4 | 29393 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PLOD2 | 9082 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0074 | 31709178 |
| PLXNB1 | 9103 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| PMEL | 10880 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PODXL | 9171 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| PODXL | 9171 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31729259 |
| POGLUT2 | 19350 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| POGLUT3 | 28496 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| POU2F2 | 9213 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| PPL | 9273 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PPP1R14A | 14871 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| PPP1R14C | 14952 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PPP1R3C | 9293 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| PREX1 | 32594 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| PRKACB | 9381 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| PRKCA | 9393 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| PRKD1 | 9407 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| PROM2 | 20685 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PRR15 | 22310 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PRR5 | 31682 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PRRG2 | 9470 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PRRG4 | 30799 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PRSS16 | 9480 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PRSS22 | 14368 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PRSS23 | 14370 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| PRSS27 | 15475 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PRSS8 | 9491 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PSG5 | 9522 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| PTAFR | 9582 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PTDSS2 | 15463 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| PTGER2 | 9594 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| PTGES | 9599 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PTGFRN | 9601 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PTGIS | 9603 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PTGS1 | 9604 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| PTGS2 | 9605 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31709178 |
| PTPN3 | 9655 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PTPN6 | 9658 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PTPRU | 9683 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| PTX3 | 9692 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| PTX3 | 9692 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31729259 |
| QSOX1 | 9756 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| RAB11FIP1 | 30265 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| RAB11FIP4 | 30267 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| RAB15 | 20150 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| RAB17 | 16523 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| RAB20 | 18260 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| RAB25 | 18238 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| RAB30 | 9770 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| RAB3IL1 | 9780 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| RALGPS1 | 16851 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| RAPGEF5 | 16862 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| RAPGEFL1 | 17428 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| RARRES1 | 9867 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| RASA3 | 20331 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| RASAL1 | 9873 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| RASSF8 | 13232 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| RBP1 | 9919 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| RBP7 | 30316 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| RCN3 | 21145 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| RETREG1 | 25964 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| RFTN1 | 30278 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| RGCC | 20369 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| RGMB | 26896 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| RGMB-AS1 | 48666 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| RHBDL2 | 16083 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| RHOD | 670 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| RHOF | 15703 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| RHOV | 18313 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| RIMS3 | 21292 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| RNF144B | 21578 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| RNF157 | 29402 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| RNR1 | 10082 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| RNR2 | 10083 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| RP1 | 10263 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| RPL13AP20 | 35709 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| RRAD | 10446 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| RTKN | 10466 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| RTP4 | 23992 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| RYR1 | 10483 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| S100A14 | 18901 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| S100A2 | 10492 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| S100A7 | 10497 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| S100A8 | 10498 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31709178 |
| S100A9 | 10499 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| S100P | 10504 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0106 | 31709178 |
| S1PR1 | 3165 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| S1PR3 | 3167 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| SAA1 | 10513 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SAA2 | 10514 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SACS | 10519 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| SALL2 | 10526 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| SAP30 | 10532 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| SAV1 | 17795 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SCEL | 10573 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| SCGB1A1 | 12523 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SCNN1A | 10599 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| SCNN1A | 10599 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31729259 |
| SDC3 | 10660 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| SEMA4A | 10729 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SEMA6D | 16770 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| SERINC2 | 23231 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| SERINC5 | 18825 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SERPINA3 | 16 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SERPINB1 | 3311 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| SERPINB2 | 8584 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| SERPINB4 | 10570 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SERPINB5 | 8949 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0064 | 31709178 |
| SERPINB7 | 13902 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SERPINE1 | 8583 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 31709178 |
| SERPINE1 | 8583 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 31709178 |
| SERPINE2 | 8951 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| SERPINE2 | 8951 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31729259 |
| SFN | 10773 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| SGCB | 10806 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| SGPP2 | 19953 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| SH2D3A | 16885 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SH3BP1 | 10824 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SH3PXD2A | 23664 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| SH3RF2 | 26299 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SH3RF3 | 24699 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| SH3YL1 | 29546 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SHISA2 | 20366 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| SHOX2 | 10854 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| SHROOM3 | 30422 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| SLC16A13 | 31037 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SLC22A17 | 23095 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| SLC22A4 | 10968 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| SLC27A2 | 10996 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| SLC28A3 | 16484 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SLC2A12 | 18067 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SLC37A1 | 11024 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SLC4A11 | 16438 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SLC52A3 | 16187 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SLC5A1 | 11036 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SLC6A11 | 11044 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SLC6A14 | 11047 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SLC8A1 | 11068 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| SLCO2A1 | 10955 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SLFN13 | 26481 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SLIT2 | 11086 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| SLITRK5 | 20295 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| SLPI | 11092 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0074 | 31709178 |
| SMAD6 | 6772 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| SMARCA1 | 11097 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| SMOX | 15862 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| SNAPC1 | 11134 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| SNX10 | 14974 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SORBS1 | 14565 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SORT1 | 11186 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SOX15 | 11196 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SOX9 | 11204 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0244 | 31709178 |
| SP6 | 14530 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SPARC | 11219 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| SPATA6L | 25472 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SPINT1 | 11246 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SPNS2 | 26992 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SPOCK1 | 11251 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| SPRR2D | 11264 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SRGN | 9361 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| SSH3 | 30581 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SSH3 | 30581 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31729259 |
| SSPN | 11322 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ST14 | 11344 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ST3GAL2 | 10863 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| ST6GALNAC5 | 19342 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| STAP2 | 30430 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| STARD10 | 10666 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| STARD8 | 19161 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| STARD9 | 19162 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| STC1 | 11373 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| STEAP1 | 11378 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0053 | 31709178 |
| STEAP2 | 17885 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| STX2 | 3403 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| STYK1 | 18889 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SULT2B1 | 11459 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| SUSD2 | 30667 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SVEP1 | 15985 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| SYBU | 26011 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| SYDE1 | 25824 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| SYNE4 | 26703 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| SYT1 | 11509 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| SYT7 | 11514 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| SYTL1 | 15584 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| SYTL2 | 15585 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| TACSTD2 | 11530 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| TBC1D30 | 29164 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| TBL1X | 11585 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| TBX2 | 11597 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| TBXAS1 | 11609 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| TERC | 11727 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| TFCP2L1 | 17925 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TFPI2 | 11761 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| TGFB1 | 11766 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0138 | 31709178 |
| TGFB1I1 | 11767 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| TGFBI | 11771 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| TGM1 | 11777 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| THBS2 | 11786 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| TIMP3 | 11822 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| TINAGL1 | 19168 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| TINCR | 14607 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TJP3 | 11829 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| TLE4 | 11840 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| TLR5 | 11851 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| TMC5 | 22999 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| TMCC1-AS1 | 49060 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| TMCC2 | 24239 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| TMCC3 | 29199 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| TMEM102 | 26722 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TMEM125 | 28275 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TMEM144 | 25633 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TMEM156 | 26260 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| TMEM158 | 30293 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31709178 |
| TMEM158 | 30293 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0042 | 31729259 |
| TMEM184A | 28797 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TMEM30B | 27254 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| TMEM38A | 28462 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TMEM40 | 25620 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| TMEM45A | 25480 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0053 | 31709178 |
| TMEM45B | 25194 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| TMEM54 | 24143 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| TMTC2 | 25440 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| TNC | 5318 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| TNC | 5318 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| TNFAIP6 | 11898 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| TNFRSF11B | 11909 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| TNFSF10 | 11925 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| TNK1 | 11940 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TNNC1 | 11943 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TNNC1 | 11943 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TNRC6C-AS1 | NA | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| TNS4 | 24352 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| TP53I3 | 19373 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| TP53INP1 | 18022 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| TPD52L1 | 12006 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| TRABD2A | 27013 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| TRAF3IP3 | 30766 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TRAF5 | 12035 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| TRAM2 | 16855 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| TRDMT1 | 2977 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| TRIM16 | 17241 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| TRIM29 | 17274 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0074 | 31709178 |
| TRPV4 | 18083 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TSPAN1 | 20657 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| TSTD1 | 35410 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| TTC22 | 26067 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TTC28 | 29179 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| TTC39A | 18657 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TTC39B | 23704 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| TTC9 | 20267 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| TTN | 12403 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| TUB | 12406 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| TUBA1A | 20766 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0032 | 31709178 |
| TWIST1 | 12428 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0191 | 31709178 |
| UCA1 | 37126 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| UNC5A | 12567 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| UpK3B | 21444 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| UpP1 | 12576 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| USP43 | 20072 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| VAMP8 | 12647 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| VGLL1 | 20985 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| VIM | 12692 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.017 | 31709178 |
| VIM | 12692 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.017 | 31729259 |
| VWA1 | 30910 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| VWDE | 21897 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| WDR35 | 29250 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| WFDC2 | 15939 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0042 | 31709178 |
| WNT10A | 13829 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| WNT5A | 12784 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| WNT5B | 16265 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| WNT6 | 12785 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| WNT7A | 12786 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0032 | 31709178 |
| XDH | 12805 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| XK | 12811 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| XYLT1 | 15516 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| YBX2 | 17948 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ZCCHC24 | 26911 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| ZDHHC13 | 18413 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ZDHHC23 | 28654 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ZEB1 | 11642 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0074 | 31709178 |
| ZEB2 | 14881 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0021 | 31709178 |
| ZNF165 | 12953 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ZNF204P | 12995 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |
| ZNF641 | 31834 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0021 | 31709178 |
| ZNF70 | 13140 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Up | 0.04 | 0.0011 | 31709178 |
| ZSCAN12P1 | 13850 | HTM | Triple Negative Breast Cancer | Ductal Carcinoma | HCC1937 | NA | FACs for CSC marker followed by Transcriptomics | Down | 0.04 | 0.0011 | 31709178 |